Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Sensorion SAS (ALSEN) Stock Price & Analysis

21 Followers

ALSEN Stock Chart & Stats

€8.28€0.22(2.73%)
At close: 5:30 PM GMT+1
€5€10€15Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
EUR 8.09 - EUR 8.30
52-Week Range
EUR 5.25 - EUR 40.40
Previous Close
EUR 8.06
Volume
N/A
Average Volume (3M)
18.91K
Market Cap
EUR 81.46M
Enterprise Value
EUR 28.69M
Total Cash (Recent Filing)
EUR 88.49M
Total Debt (Recent Filing)
EUR 3.20M
Price to Earnings (P/E)
―
Beta
0.96
Next Earnings
Mar 18, 2027 (Est.)
EPS Estimate
-2.01
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Specialized Inner-ear Focus

A dedicated focus on hearing and balance disorders gives Sensorion a clearly defined therapeutic niche and may help concentrate research resources. Targeting unmet needs can support meaningful clinical relevance and partnership interest if its development programs produce positive evidence.

Low Financial Leverage

Modest debt reduces fixed financial obligations and preserves greater flexibility than a highly leveraged structure. This gives Sensorion more room to direct available capital toward research and development, although continued losses still make broader financing needs important.

Prior Revenue Expansion

The multi-year revenue increase through 2024 indicates that Sensorion previously demonstrated an ability to generate and expand commercial or partnered revenue. That history provides a foundation for recovery potential, even though the subsequent 2025 revenue disruption materially weakens current visibility.

Bears Say

Persistent Cash Burn

Sustained operating and free-cash-flow outflows mean the company is not currently funding its activities internally. Continued burn can consume liquidity over the next several quarters and increase reliance on external financing, potentially limiting strategic flexibility or diluting existing holders.

Revenue Disruption

A drop to zero revenue represents a sharp break from the prior growth trajectory and raises uncertainty about the durability of the company’s revenue base. Without recurring revenue, funding for clinical development depends more heavily on financing, partnerships, or future product success.

Deep Ongoing Losses

Large operating and net losses show that Sensorion remains far from self-sustaining profitability and has limited operating leverage at present. Persistent deficits can constrain investment choices, reduce financial resilience, and extend dependence on capital markets while development programs continue.

Sensorion SAS News

ALSEN FAQ

What was Sensorion SAS’s price range in the past 12 months?
Sensorion SAS lowest stock price was €5.25 and its highest was €40.40 in the past 12 months.
What is Sensorion SAS’s market cap?
Sensorion SAS’s market cap is €81.46M.
When is Sensorion SAS’s upcoming earnings report date?
Sensorion SAS’s next earnings report is estimated for Mar 18, 2027 (not yet confirmed), which is in 126 days.
How were Sensorion SAS’s earnings last quarter?
Sensorion SAS released its earnings results on Sep 23, 2026. The company reported -€2.28 earnings per share for the quarter, missing the consensus estimate of -€1.39 by -€0.89.
Is Sensorion SAS overvalued?
According to Wall Street analysts Sensorion SAS’s price is currently Undervalued.
Does Sensorion SAS pay dividends?
Sensorion SAS does not currently pay dividends.
What is Sensorion SAS’s EPS estimate?
Sensorion SAS’s EPS estimate is -2.01.
How many shares outstanding does Sensorion SAS have?
Sensorion SAS has 10,312,972 shares outstanding.
What happened to Sensorion SAS’s price movement after its last earnings report?
Sensorion SAS reported an EPS of -€2.28 in its last earnings report, missing expectations of -€1.39. Following the earnings report the stock price went down -5.649%.
Which hedge fund is a major shareholder of Sensorion SAS?
Currently, no hedge funds are holding shares in FR:ALSEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology